Literature DB >> 2367319

Quantification of three lidocaine metabolites and their conjugates.

Y K Tam1, J Ke, R T Coutts, D G Wyse, M R Gray.   

Abstract

A method has been developed to quantify three lidocaine metabolites, N-ethylglycyl-2,6-xylidide (MEGX), glycyl-2,6-xylidide (GX), and 4-hydroxy-2,6-xylidine (4-OH-XY), and their conjugates in pooled human urine using enzymic hydrolysis. The commonly used enzymes, pure beta-glucuronidase, sulfatase, and a mixture of the two, were tested for their efficiencies in hydrolyzing the conjugates. Initially, it was found that 4-OH-XY was highly unstable after it was released from conjugates by beta-glucuronidase and the enzyme mixture. This problem was corrected by purging the sample with nitrogen prior to incubation. It has been determined that 4-OH-XY is present in human urine exclusively as its glucuronide. The percentage of MEGX in free and in conjugated forms (glucuronide, sulfate, and others) are 44.9 +/- 6.8, 16.6 +/- 4.5, 6.6 +/- 1.8, and 31.9 +/- 4.4, respectively. GX was present mostly in the free form (90.6 +/- 10.5%).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2367319     DOI: 10.1023/a:1015868800614

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  7 in total

1.  The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man.

Authors:  J B Keenaghan; R N Boyes
Journal:  J Pharmacol Exp Ther       Date:  1972-02       Impact factor: 4.030

2.  HPLC determination of antipyrine metabolites.

Authors:  M Eichelbaum; B Sonntag; H J Dengler
Journal:  Pharmacology       Date:  1981       Impact factor: 2.547

3.  The pharmacokinetics and metabolism of the anilide local anaesthetics in neonates. I. Lignocaine.

Authors:  G W Mihaly; R G Moore; J Thomas; E J Triggs; D Thomas; C A Shanks
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

4.  Character of adverse effects of prophylactic lidocaine in the coronary care unit.

Authors:  A W Rademaker; J Kellen; Y K Tam; D G Wyse
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

5.  An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation.

Authors:  K S Pang; J A Terrell; S D Nelson; K F Feuer; M J Clements; L Endrenyi
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

6.  Quantification of lidocaine and several metabolites utilizing chemical-ionization mass spectrometry and stable isotope labeling.

Authors:  S D Nelson; W A Garland; G D Breck; W F Trager
Journal:  J Pharm Sci       Date:  1977-08       Impact factor: 3.534

7.  High-performance liquid chromatography of lidocaine and nine of its metabolites in human plasma and urine.

Authors:  Y K Tam; S R Tawfik; J Ke; R T Coutts; M R Gray; D G Wyse
Journal:  J Chromatogr       Date:  1987-12-25
  7 in total
  1 in total

1.  Occurrence and removal of lidocaine, tramadol, venlafaxine, and their metabolites in German wastewater treatment plants.

Authors:  Paola C Rúa-Gómez; Wilhelm Püttmann
Journal:  Environ Sci Pollut Res Int       Date:  2011-09-11       Impact factor: 4.223

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.